Stroke Prevention: Extra-Cranial Carotid Artery Therapy

Crossmark: check for updates

Authors

  • Christopher J. White, MD Department of Cardiology, John Ochsner Heart & Vascular Institute, Ochsner Medical Center, 1514 Jefferson Highway, New Orleans, LA 70121, USA
  • Jose David Tafur Soto, MD Department of Cardiology, John Ochsner Heart & Vascular Institute, Ochsner Medical Center, 1514 Jefferson Highway, New Orleans, LA 70121, USA

DOI:

https://doi.org/10.17140/NOJ-6-132

Keywords:

Carotid endarterectomy; Carotid stent; Angioplasty; Embolic protection devices.

Abstract

A patient-centered approach is reasonable in candidates for carotid revascularization. The patient and their physician should discuss the available treatment options, including revascularization (either carotid artery stenting (CAS) or carotid endarterectomy
(CEA)) with their physician. There remains uncertainty regarding the value proposition for revascularization (either CEA or
CAS) in asymptomatic patients as a strategy to prevent stroke. Investigation continues into characterizing high-risk carotid plaque
subsets, but until that data is available, physicians and patients should continue to strive to achieve the best outcomes with the
information that is currently available. The other consideration in asymptomatic patients is that there is a cumulative benefit to
revascularization that is dependent on life expectancy. However, the magnitude of the benefit of revascularization, over the longer
term in the setting of multifactorial medical therapy, including statins, is not known.

Downloads

Published

2019-08-07

How to Cite

Christopher J. White, MD, & Jose David Tafur Soto, MD. (2019). Stroke Prevention: Extra-Cranial Carotid Artery Therapy. Neuro, 6(1), 13–20. https://doi.org/10.17140/NOJ-6-132

Issue

Volume 6 Issue 1 2019

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in Neuro (NEURO) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.

Most read articles by the same author(s)